Arquivos de Asma, Alergia e Imunologia
https://www.aaai-asbai.org.br/article/doi/10.5935/2526-5393.20220010
Arquivos de Asma, Alergia e Imunologia
Artigo Original

Avaliação da qualidade de vida de pacientes com urticária crônica em Aracaju - Sergipe

Analysis of the quality of life of patients with chronic urticaria in Aracaju - Sergipe

Catarina Fagundes Moreira; Juliana Monroy Leite; Julianne Alves Machado; Adriana de Oliveira Guimarães

Downloads: 0
Views: 93

Resumo

Introdução: A urticária crônica é uma doença com prevalência em pelo menos 0,1% da população, definida pela presença de pápulas pruriginosas, angioedema ou ambos por período superior a seis semanas. Os pacientes com urticária crônica têm um severo prejuízo na qualidade de vida. Objetivo: Avaliar o impacto da urticária crônica na qualidade de vida dos portadores da doença dentro de um serviço especializado no estado de Sergipe. Métodos: Trata-se de um estudo descritivo observacional a partir de dados coletados de 40 pacientes atendidos, em 2021, no Serviço de Alergia e Imunologia do Ambulatório de Alergia e Imunologia do Decós Day Hospital, através de dois questionários específicos para a avaliação da qualidade de vida na urticária crônica: o Chronic Urticaria Quality of Life Questionnaire e o Urticaria Control Test. Resultados: Foi possível identificar uma correlação positiva, através do questionário Urticaria Control Test, entre a intensidade dos sintomas e a piora da qualidade de vida (r = 0,774; p < 0,001). Também foi possível identificar uma correlação positiva entre a intensidade dos sintomas e a piora da qualidade de vida, desta vez mensurada pela escala Chronic Urticaria Quality of Life Questionnaire (r = 0,768; p < 0,001). Noventa por cento dos pacientes afirmaram se sentir cansados durante o dia porque não dormiram bem, 87,5% sentem dificuldade para se concentrar, 90% sentem-se nervosos, 80% afirmaram sentirem-se para baixo, 75% disseram ter vergonha das lesões da urticária que aparecem no corpo, e 60% tem vergonha de frequentar lugares públicos. Conclusões: A urticária crônica compromete a qualidade de vida, medida pelos questionários Urticaria Control Test e Chronic Urticaria Quality of Life Questionnaire. O comprometimento da qualidade de vida dos doentes com urticária crônica ocorre principalmente nos aspectos psicológicos, nos relacionamentos sociais e na qualidade do sono.

Palavras-chave

Urticária crônica, qualidade de vida, inquéritos e questionários.

Abstract

Introduction: Chronic urticaria is a disease with a prevalence in at least 0.1% of the population, defined by the presence of pruritic papules, angioedema or both for a period longer than six weeks. Patients with chronic urticaria have a severe loss in quality of life. Objective: To assess the impact of chronic urticaria on the quality of life of patients with the disease within a specialized service in the state of Sergipe. Methods: This is a descriptive observational study based on data collected from 40 patients treated, in 2021, at the Allergy and Immunology Service of the Allergy and Immunology Outpatient Clinic of Decós Day Hospital, using two specific questionnaires for quality assessment of life in chronic urticaria: the Chronic Urticaria Quality of Life Questionnaire and the Urticaria Control Test. Results: It was possible to identify a positive correlation, through the Urticaria Control Test questionnaire, between the intensity of symptoms and the worsening of quality of life (r = 0.774, p < 0.001). It was also possible to identify a positive correlation between the intensity of symptoms and worsening quality of life, this time measured by the Chronic Urticaria Quality of Life Questionnaire scale (r = 0.768, p < 0.001). 90% said they felt tired during the day because they didnt sleep well, 87.5% found it difficult to concentrate, 90% felt nervous, 80% said they felt down, 75% said they were ashamed of the urticaria lesions that appear on the body and 60% are ashamed to go to public places. Conclusions: Chronic urticaria compromises quality of life, as measured by the Urticaria Control Test and the Chronic Urticaria Quality of Life Questionnaire. The impairment of the quality of life of patients with chronic urticaria occurs mainly in the psychological aspects, in social relationships and in the quality of sleep.

Keywords

Chronic urticaria, quality of life, surveys and questionnaires.

Referências

1. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869-73.

2. Grattan C, Powell S, Humphreys F. British Association of Dermatologists. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol. 2001;144:708-14.

3. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005 Aug;60(8):1073-8.

4. Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, Gagnon JP, et al. Regulatory issues for health-related quality of life - PhRMA Health Outcomes Committee workshop, 1999. Value Health. 2002;5(1):14‑25.

5. O’Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997 Feb;136(2):197‑201.

6. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous disease. J Am Acad Dermatol. 1997;37:41-50.

7. Le Cleach L, Chassany O, Levy A, Wolkenstein P, Chosidow O. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials. Dermatology. 2008;216(1):46-55.

8. Valle SOR, Dortas-Junior SD, Dias GAC, Motta AA, FalcaoAmaral CS, Martins EAPR, et al. Ferramentas para avaliação e acompanhamento da urticária crônica. Arq Asma Alerg Imunol. 2018;2(2):209-24.

9. Zuberbier T, Aberer W, Asero R, Abdul Latiff A, Baker D, BallmerWeber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-414.

10. Kozel MMA, Sabroe RA. Chronic Urticaria. Etiology, management and current and future treatment options. Drugs. 2004;64:2515‑36.

11. Dibbern Jr DA, Dreskin SC. Urticaria and angioedema: an overview. Immunol Allergy Clin North Am. 2004;24:141-62.

12. Delong LK, Culler SD, Saini SS, Beck LA, Chen SC. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol. 2008 Jan;144(1):35-9.

13. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011 Mar;66(3):317‑30.

14. Zuberbier T. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014 Jul;69(7):868-87.

15. Associação Brasileira de Alergia e Imunologia – ASBAI [site na Internet]. Urticária não é emocional, mas o impacto da doença pode levar à depressão. Disponível em: https://asbai.org.br/urticaria-nao-e-emocional-mas-o-impacto-da-doencapode-levar-a-depressao/#:~:text=Urtic%C3%A1ria%20e%20depress%C3%A3o%20%E2%80%93%20A%20urtic%C3%-A1ria,da%20vida%20social%20e%20afetiva. Acessado em: 20/05/2021.

16. Tharp MD. Chronic urticaria: Pathophysiology and treatment approaches. J Allergy Clin Immunol. 1996;98:S325-30.

17. Greaves MW. Chronic urticaria. N Engl J Med. 1995;29:1767-72.

18. Naughton MJ, Shumaker AS. The case for domains of function in quality of life assessment. Qual Life Res. 2003;12(Suppl 1):73‑80.

19. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003 Sep;149(3):572-7.

20. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angiodedema: a broad view for clinicians. Arch Intern Med. 2001;161:2417-29.

21. Kanwar AJ, Greaves MW. Approach to the patient with chronic urticaria. Hospital Pratice. 1996;15:175-89.


Submetido em:
11/08/2021

Aceito em:
13/11/2021

6a0629baa953951f7c024073 aaai Articles
Links & Downloads

Arq Asma Alerg Imunol

Share this page
Page Sections